Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.

Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.

Bibliographic Details
Main Authors:	Kehoe, P, Williams, J, Lovestone, S, Wilcock, G, Owen, M
Format:	Journal article
Language:	English
Published:	1996

Similar Items

Presenilin-1 polymorphism and Alzheimer's disease [6]
by: Kehoe, P, et al.
Published: (1996)

The Presenilins and Alzheimer Disease
by: G. Lévesque, et al.
Published: (2020-12-01)

Presenilin-1 intron 8 polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease.
by: Tysoe, C, et al.
Published: (1997)

Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease.
by: Kehoe, P, et al.
Published: (1996)

Apolipoprotein E genotyping in Alzheimer's disease. The UK Alzheimer's Disease Genetic consortium.
by: Lovestone, S, et al.
Published: (1996)

Presenilins in Alzheimer’s disease and frontotemporal dementia
by: Shen Jie
Published: (2012-02-01)

Presenilin mutations and their impact on neuronal differentiation in Alzheimer’s disease
by: Mercedes A Hernandez-Sapiens, et al.
Published: (2022-01-01)

A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease.
by: Tysoe, C, et al.
Published: (1998)

The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.
by: Kehoe, P, et al.
Published: (1998)

Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK.
by: Dow, D, et al.
Published: (1999)

Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer’s Disease
by: Youngsoon Yang, et al.
Published: (2023-05-01)

APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease.
by: Chalmers, K, et al.
Published: (2004)

Tacrine for Alzheimer's disease: why is it not available on prescription to UK sufferers?
by: Wilcock, G
Published: (1994)

Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.
by: Culpan, D, et al.
Published: (2003)

Tau phosphorylation in cells transfected with wild-type or an Alzheimer's disease mutant Presenilin 1.
by: Irving, N, et al.
Published: (1997)

Switched Aβ43 generation in familial Alzheimer’s disease with presenilin 1 mutation
by: Nobuto Kakuda, et al.
Published: (2021-11-01)

Alzheimer's Disease-like Alterations in Peripheral Cells from Presenilin-1 Transgenic Mice
by: Anne Eckert, et al.
Published: (2001-04-01)

Presenilin: A Multi-Functional Molecule in the Pathogenesis of Alzheimer’s Disease and Other Neurodegenerative Diseases
by: Yang Sun, et al.
Published: (2024-02-01)

No observed effect on brain vasculature of Alzheimer’s disease-related mutations in the zebrafish presenilin 1 gene
by: Karissa Barthelson, et al.
Published: (2021-01-01)

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
by: Kehoe, P, et al.
Published: (2007)

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease.
by: Kehoe, P, et al.
Published: (1999)

Presenilin-1-Derived Circular RNAs: Neglected Epigenetic Regulators with Various Functions in Alzheimer’s Disease
by: Nima Sanadgol, et al.
Published: (2023-09-01)

Protein Predictive Modeling and Simulation of Mutations of Presenilin-1 Familial Alzheimer’s Disease on the Orthosteric Site
by: Alejandro Soto-Ospina, et al.
Published: (2021-06-01)

The relationship between CAV-1 and cerebral amyloid angiopathy in Alzheimer's disease
by: Chalmers, K, et al.
Published: (2004)

Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease.
by: Culpan, D, et al.
Published: (2007)

Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population
by: Ayako Suzuki, et al.
Published: (2016-03-01)

Association of interleukin-1 gene polymorphisms with Alzheimer's disease.
by: Nicoll, J, et al.
Published: (2000)

Treating Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1995)

Treatment for Alzheimer's disease.
by: Wilcock, G
Published: (2000)

Neurotrophins in Alzheimer's disease
by: Wilcock, G
Published: (2002)

Changes in the expression of the Alzheimer's disease-associated presenilin gene in drosophila heart leads to cardiac dysfunction
by: Li, A., et al.
Published: (2012)

Velnacrine for Alzheimer's disease.
by: Birks, J, et al.
Published: (2004)

Recommended minimum data to be collected in research studies on Alzheimer's disease. The MRC (UK) Alzheimer's Disease Workshop Steering Committee.
by: Wilcock, G, et al.
Published: (1989)

Human-Induced Neurons from Presenilin 1 Mutant Patients Model Aspects of Alzheimer’s Disease Pathology
by: Sean Schrank, et al.
Published: (2020-02-01)

Alzheimer's Disease Associated Presenilin 1 Interacts with HC5 and ZETA, Subunits of the Catalytic 20S Proteasome
by: Geert Van Gassen, et al.
Published: (1999-10-01)

Mitophagy Failure in Fibroblasts and iPSC-Derived Neurons of Alzheimer’s Disease-Associated Presenilin 1 Mutation
by: Patricia Martín-Maestro, et al.
Published: (2017-09-01)

The renin angiotensin system in Alzheimer's disease - Do updates high-light a clinical and biological dichotomy?
by: Kehoe, P, et al.
Published: (2006)

Hyperinsulinaemia and Alzheimer's disease.
by: Razay, G, et al.
Published: (1994)

Galantamine in Alzheimer's disease.
by: Razay, G, et al.
Published: (2008)

Age and Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1983)